Christina is the managing editor of The American Journal of Managed Care® (AJMC®) and The American Journal of Accountable Care® (AJAC), and joined AJMC® in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.
She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.
ALPINE, SEQUOIA Findings: Zanubrutinib Offers Improved HRQOL in CLL/SLL
June 11th 2022Abstracts presented at the 2022 European Hematology Association Congress demonstrate superior health-related quality of life (HRQOL) outcomes among patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) taking zanubrutinib.
Read More
Abstracts Demonstrate Long-term, Real-world Advantages of Zanubrutinib in WM
June 10th 2022In abstracts featured at the 2022 European Hematology Association Congress, investigators detailed long-term results of the ASPEN phase 3 trial and an expanded access study of zanubrutinib in patients with Waldenström macroglobulinemia (WM).
Read More
Genetics, Immunophenotyping Help Drive CLL Treatment Selection, but More Knowledge Needed
June 10th 2022An education session at the 2022 European Hematology Association Congress featured updates on using genetic and immune characteristics to select the optimal treatment pathway in chronic lymphocytic leukemia (CLL).
Read More
EHA2022 to Offer Array of Research on Cancer Treatments, Blood Disorders
June 8th 2022The 2022 European Hematology Association (EHA) Congress will be the group’s first hybrid meeting, in which investigators will convene both virtually and in Vienna, Austria, from June 9-12, 2022, to present cutting-edge findings in the realm of oncology and hematology.
Read More
Reversing Pandemic-Era Trends in Alcoholic Liver Disease Requires Empathetic, Multidisciplinary Care
May 24th 2022During a State-of-the-Art Lecture at Digestive Disease Week 2022, Jessica L. Mellinger, MD, MSc, explained how the COVID-19 pandemic has driven increases in rates of alcohol use and associated liver disease, as well as what can be done at the clinic, societal, and policy levels to address these trends.
Read More
Complex Questions Surround Potential of Weight Loss Procedures to Reverse NAFLD
May 23rd 2022Evidence shows that weight loss achieved through bariatric and endoscopic surgery can help treat and reverse nonalcoholic fatty liver disease (NAFLD), but optimal procedure selection and timing vary by patient factors, according to speakers at Digestive Disease Week 2022.
Read More
Posters Show Success of RBX2660 in Reducing C difficile Recurrence, Reviving Microbiome
May 22nd 2022A pair of posters presented at Digestive Disease Week 2022 showed the efficacy of an investigational biotherapeutic in preventing Clostridioides difficile infection recurrence and restoring the microbiome.
Read More
The Far-Reaching Effects of Health Disparities on the Gut Microbiome and Health
May 22nd 2022Speakers at Digestive Disease Week 2022 presented research on how health disparities and socioeconomic factors can contribute to changes in the gut microbiome that have implications for cancer risk, immune health, and overall well-being.
Read More
Use of AI in Gastroenterology Can Move Beyond “Cool Tools” to Improve Practice Efficiency
May 21st 2022As artificial intelligence (AI) technology in the gastrointestinal field continues to advance, speakers at Digestive Disease Week 2022 discussed how these tools can be put into practice to improve efficiency, reduce physician burnout, and reap cost savings.
Read More
Importance of Microbiome, Disease Prevention Among Topics to Be Discussed at DDW 2022
May 18th 2022Digestive Disease Week (DDW) 2022, held virtually and in San Diego, California, from May 21 to 24, will feature research and presentations exploring new ways to prevent and treat digestive diseases.
Read More
Top 5 Most-Read AJMC® Journal Articles of 2021
December 25th 2021In 2021, the articles published in the peer-reviewed The American Journal of Managed Care® (AJMC®) explored responses to the COVID-19 pandemic, the potential of health policy reforms, the importance of population health, and much more.
Read More
Despite Expanding Array of Psoriasis Treatments, Opportunities for Improvement Remain
April 23rd 2021There are a number of new biologic options for treating psoriasis, but undertreatment is still a concern, and more long-term data are needed, according to Junko Takeshita, MD, PhD, MSCE, at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
Read More
New Understanding of Migraine Biology Paves Way for Innovative Therapy Options
April 23rd 2021Now that investigators have a better understanding of the biological mechanisms of migraine, new treatment and prevention options are making their way to patients and fueling an exciting time for the field, according to a presenter at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
Read More
Overcoming the Unique Hurdles to Biosimilar Uptake in Oncology
April 23rd 2021With the costs of biologic drugs increasing, biosimilars have emerged as an attractive option for containing costs and expanding access to treatment. However, some barriers to wider uptake still need to be addressed, according to a presentation at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
Read More
Top 5 Most-Read Multiple Sclerosis Articles of 2020
December 27th 2020The coronavirus disease 2019 (COVID-19) pandemic dominated headlines for much of 2020, and most of the top 5 multiple sclerosis articles of this year discussed the effects of COVID-19 on patients with this disease. Others touched on physician and patient assessments of relapse and potential new treatments for neural damage.
Read More
Top 5 Most-Read Inflammation Articles of 2020
December 23rd 2020This year, the most popular articles and interviews related to the role of inflammation in asthma and other conditions touched on the mechanisms of inflammation, patterns of inhaler use, and the real-world impacts of the monoclonal antibody dupilumab.
Read More
Moving Beyond Precision Oncology to “Precision Prevention” in Oncology Practices
November 11th 2020In a pair of sessions at the Quality Cancer Care Alliance Virtual Fall Leadership Summit, speakers discussed the promise of precision medicine for not only informing individuals’ cancer treatment decisions but also identifying individuals at high risk before disease develops.
Read More
Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs
October 23rd 2020In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.
Read More